Abstract:The large diversity of structures and unique bonding modes of organometallic complexes make them possible to act as promising candidate therapeutic agents. In this study, the new type of ferrocene-substituted dithio-o-carborane conjugates (FcSB1, FcSB2, and FcSBCO) has been synthesized, and their in vitro antineoplastic activities have been explored by means of the electrochemical study, the real time cell electronic sensing (RT-CES) system, and biological assays. The conjugate-cell interactions were first monitored by electrochemistry, and the results show different cell uptake efficiency for FcSB1, FcSB2, and FcSBCO toward target cells. Both the highly hydrophobic ferrocenyl and carboranyl groups render the conjugates able to rapidly enter cells and exert acute cytotoxicity after 4 h incubation in serum-free media. However, FcSB1, FcSB2, and FcSBCO display different inhibition efficiencies toward SMMC-7721 and HepG2 cancer cells via the G(0)/G(1) arrest mechanism in a physiological environment. The anticancer activity is in the order FcSB2 > FcSB1 > FcSBCO, which is parallel to the order of the redox potentials of the ferrocenyl groups in the three complexes. In particular, FcSB1 and FcSB2 display a potent selective inhibition effect on the proliferation of the cancer cell lines SMMC-7721 and HcpG2, but almost no effect on the normal cell line, the human embryonic lung fibroblast (HELF) cells. Thus, these results may provide some clues for use of the ferrocene-carborane conjugates in developing anticancer drugs.

C2 symmetric borneol-porphyrin hybrids: Synthesis, characterization, electronic structure and their anti-cancer behaviors

meso -borneol- and meso -carbazole-substituted porphyrins: multifunctional chromophores with tunable electronic structures and antitumor activities

Borneol-triarylcorrole hybrids with chiral-optical response and anticancer behaviours

New ferrocene cyclopalladated compounds: synthesis, X-ray single crystal structure and in vitro anticancer activity study

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Dibenzoxanthene- β -lactam hybrids as potential antioxidant and anticancer agents: Synthesis, biological evaluation, and docking study

A "D-π-A" type Ni II porphyrin-BODIPY hybrid: Expansion of visible-light absorption and antitumor activity of lymphoma cells

Lysosomal Targeted Cyclometallic Iridium(III) Salicylaldehyde-Coumarin Schiff Base Complexes and Anticancer Application

Novel ferrocene cyclopalladated compounds: Synthesis, and in‐vitro antitumor activity study

Design, synthesis and biological evaluation of marine naphthoquinone-naphthol derivatives as potential anticancer agents

Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents.

Lysosomal Targeted Cyclometallic Iridium(Ⅲ) Salicylaldehyde-Coumarin Schiff Base Complexes and Anticancer Application

Mixed N‐heterocyclic carbene and benzyl‐, phenethyl‐, and biphenylamine coordinated Pd complexes: Anticancer activities and stereo‐electronic effects

Synthesis and Anti-cancer Activity of 3-Substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives.

Design and synthesis of fluorescent BODIPY derivatives with D-A structure for cancer cell imaging

New Potential Anticancer Agent Of Carborane Derivatives: Selective Cellular Interaction And Activity Of Ferrocene-Substituted Dithio-O-Carborane Conjugates

A symmetrical tetra N-heterocyclic carbene binuclear silver(I) complex: synthesis, characterization and anticancer study

Elaborated DNA-binding Specialities, in Vitro Medicated Apoptosis and Restrained Malignancy of Neotype Water-Soluble Cationic Porphyrin Acylhydrazone Cu-complex

A novel ferrocene-palladium metal complex: synthesis, single crystal structure, in vitro cytotoxicity study and molecular docking

Synthesis and antitumor study of novel porphyrin–coumarin derivatives for chemotherapy and photodynamic therapy

Facile Synthesis and Biological Evaluation of Novel Symmetrical Biphenyls As Antitumor Agents.